These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26840500)

  • 1. Preventing Infections in Sickle Cell Disease: The Unfinished Business.
    Obaro SK; Iroh Tam PY
    Pediatr Blood Cancer; 2016 May; 63(5):781-5. PubMed ID: 26840500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine.
    Alexander E; Telfer P; Rashid H; Ali KA; Booy R
    J Infect Public Health; 2008; 1(1):40-4. PubMed ID: 20701844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors and incidence of acute chest syndrome or pneumonia among children with sickle cell disease presenting with a fever: a 17-year review.
    Chang TP; Kriengsoontorkij W; Chan LS; Wang VJ
    Pediatr Emerg Care; 2013 Jul; 29(7):781-6. PubMed ID: 23823253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal infections and sickle cell disease in Africa: does absence of evidence imply evidence of absence?
    Obaro S
    Arch Dis Child; 2009 Sep; 94(9):713-6. PubMed ID: 19414433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Brown BJ; Madu A; Sangeda RZ; Nkya S; Peprah E; Paintsil V; Mmbando BP; Gyamfi J; Okocha CE; Asala SA; Nembaware V; Jonas M; Kengne AP; Chimusa ER; Nguweneza A; Isa HA; Nnebe-Agumadu U; Adekile AD; Osei-Akoto A; Ohene-Frempong K; Balandya E; Nnodu OE; Wonkam A; Makani J;
    Hemoglobin; 2021 May; 45(3):163-170. PubMed ID: 34355623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections in children with sickle cell anemia. Special reference to pneumococcal and salmonella infections.
    Landesman SH; Rao SP; Ahonkhai VI
    Am J Pediatr Hematol Oncol; 1982; 4(4):407-18. PubMed ID: 7168489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening.
    Hardie R; King L; Fraser R; Reid M
    Ann Trop Paediatr; 2009 Sep; 29(3):197-202. PubMed ID: 19689861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.
    Ellison AM; Ota KV; McGowan KL; Smith-Whitley K
    Pediatr Infect Dis J; 2012 May; 31(5):534-6. PubMed ID: 22228232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PNEUMOCOCCAL VACCINE IN ADULTS REDUCES THE RISK OF INFECTIONS CAUSED BY STREPTOCOCCUS PNEUMONIAE].
    Belocerkovskaja JG; Romanovskih AG; Styrt EA
    Klin Med (Mosk); 2016; 94(1):61-6. PubMed ID: 27172726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pneumococcal bacteremia in children with sickle cell disease.
    Patel A; Zuzo A; Imran H; Siddiqui AH
    Pediatr Hematol Oncol; 2013 Aug; 30(5):432-6. PubMed ID: 23570543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
    Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
    Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.
    Szczepanek SM; Roberts S; Rogers K; Cotte C; Adami AJ; Bracken SJ; Salmon S; Secor ER; Thrall RS; Andemariam B; Metzger DW
    PLoS One; 2016; 11(2):e0149261. PubMed ID: 26910228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of 7-valent pneumococcal conjugate vaccine.
    Ghaffar F
    Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections and immunizations of children with sickle cell disease.
    Overturf GD
    Adv Pediatr Infect Dis; 1999; 14():191-218. PubMed ID: 10079855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antipneumococcal vaccines in sickle-cell anemia and asplenia].
    Cohen R
    Presse Med; 2003 Sep; 32(28 Suppl):S12-4. PubMed ID: 14631639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
    Weil-Olivier C; Gaillat J
    Vaccine; 2014 Apr; 32(18):2022-6. PubMed ID: 24565755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal vaccination rates in children with sickle cell disease.
    Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
    J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infections and antibiotic prophylaxis in sickle cell disease].
    Lepage P; Dresse MF; Forget P; Schmitz V; Hoyoux C
    Rev Med Liege; 2004 Mar; 59(3):145-8. PubMed ID: 15139401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccine failure in a child with sickle-cell disease: a case report.
    Castro R; DelDuca V
    Del Med J; 1987 Jan; 59(1):21-2. PubMed ID: 3817232
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.